BSC® Solutions
VOICES
Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

What is MDR? Understanding Medical Device Regulation Compliance
Common imputation methods and when to use them

What is MDR? Understanding Medical Device Regulation Compliance
Common imputation methods and when to use them

What is MDR? Understanding Medical Device Regulation Compliance
Common imputation methods and when to use them
Published on Jan 6, 2026
•
•
3 min read time
What is MDR?
MDR stands for Medical Device Regulation - a comprehensive regulatory framework that governs the development, manufacturing, and distribution of medical devices within the European Union. The regulation was officially published in 2017 and became fully applicable on May 26, 2021, marking a significant shift in how medical devices are regulated and approved for market access.
Why MDR Matters
The implementation of MDR was driven by several critical factors:
Enhanced Patient Safety: The regulation introduces stricter requirements for clinical evidence and post-market surveillance
Improved Transparency: Greater requirements for device traceability and information sharing
Harmonized Standards: Creates consistent regulatory requirements across all EU member states
Future-Proofing: Addresses emerging technologies and novel device types
Key Changes Under MDR
Classification System Updates
MDR introduces more stringent classification rules, potentially moving devices to higher risk categories that require more rigorous clinical evidence and Notified Body involvement.Enhanced Clinical Evidence Requirements
More comprehensive clinical data requirements
Mandatory clinical investigations for high-risk devices
Stricter requirements for clinical evaluation reports (CERs)
Post-Market Surveillance (PMS)
Enhanced post-market surveillance requirements
Mandatory post-market clinical follow-up (PMCF) for certain devices
More detailed safety reporting obligations
Unique Device Identification (UDI)
Implementation of UDI system for device traceability
Enhanced labeling requirements
Improved device identification throughout the supply chain
MDR Compliance Challenges
Many medical device companies face significant challenges in achieving MDR compliance:
Technical DocumentationMore comprehensive technical documentation requirements
Enhanced risk management documentation
Stricter quality management system requirements
Clinical EvidenceDifficulty in gathering sufficient clinical data for legacy devices
Challenges in conducting new clinical studies
Complex requirements for clinical evaluation reports
Notified Body CapacityLimited availability of Notified Bodies
Extended review timelines
Increased costs for conformity assessment
The Impact on Different Stakeholders
Medical Device ManufacturersIncreased regulatory burden and costs
Need for enhanced quality management systems
Requirement for more comprehensive clinical data
Healthcare ProvidersImproved device safety and performance information
Better traceability of devices
Enhanced post-market surveillance data
PatientsGreater confidence in device safety
Improved access to device information
Enhanced protection through stricter regulations
How Consulting Services Can Help
Navigating MDR compliance requires specialized expertise and strategic planning. Professional consulting services can provide:
Strategic PlanningGap analysis of current compliance status
Development of MDR transition roadmaps
Risk assessment and mitigation strategies
Technical Documentation SupportPreparation of enhanced technical documentation
Clinical evaluation report development
Risk management documentation assistance
Quality Management System EnhancementQMS gap analysis and improvement
Process optimization for MDR compliance
Staff training and competency development
Clinical Evidence StrategyClinical data gap analysis
PMCF study design and implementation
Clinical evaluation planning and execution
Notified Body InteractionPreparation for Notified Body audits
Documentation review and optimization
Communication strategy with regulatory bodies
FDA Perspective on MDR
The U.S. Food and Drug Administration (FDA) recognizes the importance of international harmonization in medical device regulation. While the FDA operates under different regulatory frameworks, there are areas of alignment between FDA requirements and MDR:Both emphasize the importance of clinical evidence
Risk-based classification systems
Post-market surveillance requirements
Quality management system requirements
The FDA has published guidance documents that acknowledge the value of international standards and the importance of global regulatory harmonization for medical device safety and effectiveness.
Conclusion
MDR represents a fundamental shift in medical device regulation that requires careful planning and strategic implementation. The regulation's emphasis on enhanced safety, transparency, and clinical evidence creates both challenges and opportunities for medical device companies.
Successfully navigating MDR compliance requires:Comprehensive understanding of regulatory requirements
Strategic planning and resource allocation
Expertise in clinical evidence development
Robust quality management systems
Effective stakeholder communication
This blog post provides general information about MDR requirements. For specific compliance guidance tailored to your organization, please contact our consulting team for personalized support.

Subscribe updates
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

Subscribe updates
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

Subscribe updates
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

Subscribe updates
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Use your preferred LLM to explore BSC®
Use your preferred LLM to explore BSC®
